Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1967 1
1969 2
1970 1
1971 1
1989 2
1991 1
1992 3
1993 1
1994 2
1995 2
1996 1
1997 6
1998 4
1999 4
2000 5
2001 3
2002 3
2004 2
2005 2
2007 1
2009 2
2010 2
2011 3
2013 2
2014 5
2015 3
2016 9
2017 10
2018 5
2019 7
2020 5
2021 6
2022 3
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Inoculum effect of β-lactam antibiotics.
Lenhard JR, Bulman ZP. Lenhard JR, et al. J Antimicrob Chemother. 2019 Oct 1;74(10):2825-2843. doi: 10.1093/jac/dkz226. J Antimicrob Chemother. 2019. PMID: 31170287 Free PMC article. Review.
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.
Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, Bode B, Aronoff S, Holland C, Carlin D, King KL, Wilder RL, Pillemer S, Bonvini E, Johnson S, Stein KE, Koenig S, Herold KC, Daifotis AG; Protégé Trial Investigators. Sherry N, et al. Lancet. 2011 Aug 6;378(9790):487-97. doi: 10.1016/S0140-6736(11)60931-8. Epub 2011 Jun 28. Lancet. 2011. PMID: 21719095 Free PMC article. Clinical Trial.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Holman RR, et al. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. N Engl J Med. 2017. PMID: 28910237 Free PMC article. Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Synergistic combinations of polymyxins.
Lenhard JR, Nation RL, Tsuji BT. Lenhard JR, et al. Int J Antimicrob Agents. 2016 Dec;48(6):607-613. doi: 10.1016/j.ijantimicag.2016.09.014. Epub 2016 Oct 24. Int J Antimicrob Agents. 2016. PMID: 27865626 Free PMC article. Review.
Shifting Gears: The Future of Polymyxin Antibiotics.
Lenhard JR, Bulman ZP, Tsuji BT, Kaye KS. Lenhard JR, et al. Antibiotics (Basel). 2019 Apr 12;8(2):42. doi: 10.3390/antibiotics8020042. Antibiotics (Basel). 2019. PMID: 31013818 Free PMC article. Review.
β-Adrenoceptor assays.
Kenakin T, Lenhard JM, Paulik MA. Kenakin T, et al. Among authors: lenhard jm. Curr Protoc Pharmacol. 2001 May;Chapter 4:Unit4.6. doi: 10.1002/0471141755.ph0406s00. Curr Protoc Pharmacol. 2001. PMID: 21971805 No abstract available.
Research priorities towards precision antibiotic therapy to improve patient care.
Bulman ZP, Wicha SG, Nielsen EI, Lenhard JR, Nation RL, Theuretzbacher U, Derendorf H, Tängdén T, Zeitlinger M, Landersdorfer CB, Bulitta JB, Friberg LE, Li J, Tsuji BT; International Society of Anti-Infective Pharmacology; European Society of Clinical Microbiology and Infectious Diseases Pharmacokinetics and Pharmacodynamics of Anti-Infectives Study Group; International Society of Antimicrobial Chemotherapy Anti-Infective Pharmacology Working Group. Bulman ZP, et al. Among authors: lenhard jr. Lancet Microbe. 2022 Oct;3(10):e795-e802. doi: 10.1016/S2666-5247(22)00121-5. Epub 2022 Jun 28. Lancet Microbe. 2022. PMID: 35777386 Free article. Review.
Preclinical developments in type 2 diabetes.
Lenhard JM, Gottschalk WK. Lenhard JM, et al. Adv Drug Deliv Rev. 2002 Nov 5;54(9):1199-212. doi: 10.1016/s0169-409x(02)00092-3. Adv Drug Deliv Rev. 2002. PMID: 12393301 Review.
110 results